Vascular Lung Disease Flashcards
Blood clots that occlude large pulmonary arteries are almost always ______ in origin
Embolic
Usual source of Pulmonary Embolus
Thrombi in the deep veins of the leg (95%)
Risk factors for pulmonary embolism
Immobilization
Hypercoagulable states
Indwelling central venous lines
Examples of hypercoagulable states
PrimarY (APAS, prothrombin mutations)
Secondary (Cancer, pregnancy, OCP use)
Histology of pulmonary infarction
Ischemic necrosis of the lung substance within the area of the hemorrhage
Pulmonary hypertension
Pulmonary blood pressure reaches 1/4 of systemic blood pressure
Groups of pulmonary hypertension
Pulmonary arterial hypertension
Pulmonary hypertension with left heart disease
Pulmonary hypertension with lung disease and/or hyoxemia
Pulmonary hypertension due to chronic thrombosis and/or embolic disease
Miscellaneous pulmonary hypertension
Structural cardiopulmonary conditions that increase pulmonary blood flow or pressure, pulmonary vascular resistance, or left heart resistance to blood flow;
Chronic Obstructive or interstitial lung disease
Antecedent congenital or acquired heart disease
Recurrent thrombo-emboli
Connective tissue disease
Obstructive sleep apnea
Chronic obstructive or interstitial LD
Destruction of lung parenhyma->fewer alveolar capillaries -> increased pulmonary arterial resitance -> elevated pressure
Antecedent congenital or aqcuired heart disease
Mitral stenosis -> increase in Left atrial Pressure -> increased pulmonary venous pressure -> increase in pulmonary arterial pressure
Recurrent thrombo-emboli
Obstructing emboli -> reduction in functional cross-sectional area of the pulmonary vascular resistance
Connective tissue disease
Systemic sclerosis -> involve pulmonary vasculature -> inflammation; intimal fibrosis, medial hypertrophy -> pulmonary hypertension
Obstructive sleep apnea
Significant contributor to pulmonary hypertension and cor pulmonale
Mutations in the ___________________ signalling pathway can lead to pulmonary hypertension
Bone Morphogenic Protein receptor Type 2 signalling pathway
Obstruction to the vasculature caused by proliferation of endotheial, sooth muscle and intimal cells accompanied by concentric laminar intimal fibrosis
Pulmonary hypertension